KPC Pharmaceuticals,Inc. (SHA:600422)
China · Delayed Price · Currency is CNY 8.11
+0.11 (1.38%)
Sep 30, 2026, 3:00 PM CST
KPC Pharmaceuticals,Inc. Market Cap
KPC Pharmaceuticals,Inc. has a market cap or net worth of 6.14 billion as of October 2, 2026. Its market cap has decreased by -42.20% in one year.
Market Cap
6.14B
Enterprise Value
7.64B
Revenue
4.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
8.11
ChartMarket Cap Chart
Since March 21, 2006, KPC Pharmaceuticals,Inc.'s market cap has increased from 1.22B to 6.14B, an increase of 402.32%. That is a compound annual growth rate of 8.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 6.14B | -35.43% |
| Dec 31, 2025 | 9.51B | -20.76% |
| Dec 31, 2024 | 12.00B | -24.12% |
| Dec 29, 2023 | 15.81B | 47.68% |
| Dec 30, 2022 | 10.71B | 27.78% |
| Dec 31, 2021 | 8.38B | 27.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hunan Er-Kang Pharmaceutical | 6.72B |
| Sunflower Pharmaceutical Group | 6.66B |
| Bide Pharmatech | 6.60B |
| Cisen Pharmaceutical | 6.58B |
| Guizhou Bailing Group Pharmaceutical | 6.40B |
| Frontier Biotechnologies | 6.32B |
| Chongqing Pharscin Pharmaceutical | 6.22B |
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 6.10B |